Author:
Bazan Naglaa Samir,Sabry Nirmeen Ahmed,Rizk Amal,Mokhtar Sherif,Badary Osama
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference33 articles.
1. Takeuchi F, Kashida M, Okazaki O, Tanaka Y, Fukuda S, Kashima T, et al. Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients. Circ J. 2010;74:977–82.
2. Cavallari LH, Shin J, Minoli A, Perera MA. Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. Pharmacotherapy. 2011;31(12):1192–207.
3. Gage BF, Lesko LJ. Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis. 2008;25:45–51.
4. Bristol-Meyers Squibb Company. Coumadin® tablets (warfarin sodium tablets, USP) crystalline; Coumadin® for injection (warfarin sodium for injection, USP). Available at: http://www.accessdata.fda.gov./drugsatfda_docs/label/2010/009218s108lbl.pdf . Accessed June 2012.
5. Hillman MA, Wilke RA, Yale SH, Vidaillet HJ, Caldwell MD, Glurich I, et al. A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin Med Res. 2005;3:137–45.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献